Sarcoma Biopsy Market Positive Long-term Growth Outlook 2023-2028
Biopsy is a procedure of removing of a small amount of tissue for examination under a microscope. Imaging tests may suggest the diagnosis of sarcoma, but biopsy is performed to confirm the diagnosis and to find out the type of sarcoma. Several types of biopsies are used to diagnose sarcomas and most biopsies are needle biopsies, in which needle is used to access the suspicious tissue of sarcoma.
The global sarcoma biopsy market was valued at US$ 197.94 million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).
Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.
